HER1, HER2, HER3 and HER4 gene copy number and protein expression in non-small cell lung cancer

被引：0
|
作者：
Jeon, Y. [1 ]
Kim, Y. [1 ]
Sung, S. [1 ]
Seo, J. [1 ]
Chung, D. [1 ]
机构：
[1] Seoul Natl Univ, Coll Med, Boramae Hosp, Seoul Natl Univ Hosp,Dept Pathol & Thorac Surg, Seoul, South Korea
来源：
HISTOPATHOLOGY | 2008年 / 53卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
804
引用
收藏
页码：350 / 350
页数：1
相关论文
共 50 条
  • [31] HercepTest: HER2 expression and gene amplification in non-small cell lung cancer
    Cox, G
    Vyberg, M
    Melgaard, B
    Askaa, J
    Oster, A
    O'Byrne, KJ
    INTERNATIONAL JOURNAL OF CANCER, 2001, 92 (04) : 480 - 483
  • [32] P95HER2 TRUNCATED FORM AND HER2 GENE COPY NUMBER IN NON-SMALL-CELL LUNG CANCER (NSCLC)
    Cappuzzo, Federico
    Cho, Yong Gon
    Ali, Greta
    Incarbone, Matteo
    Destro, Annarita
    Terracciano, Luigi
    Fontanini, Gabriella
    Marchetti, Antonio
    Roncalli, Massimo
    Varella-Garcia, Marileila
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S505 - S506
  • [33] Specific antibodies and sensitive immunoassays for the human epidermal growth factor receptors (HER2, HER3, and HER4)
    Broughton, Marianne Nordlund
    Westgaard, Arne
    Paus, Elisabeth
    Oijordsbakken, Miriam
    Henanger, Karoline J.
    Naume, Bjorn
    Bjoro, Trine
    TUMOR BIOLOGY, 2017, 39 (06) : 1 - 11
  • [34] In situ detection of HER2:HER2 and HER2:HER3 protein–protein interactions demonstrates prognostic significance in early breast cancer
    Melanie Spears
    Karen J. Taylor
    Alison F. Munro
    Carrie A. Cunningham
    Elizabeth A. Mallon
    Chris J. Twelves
    David A. Cameron
    Jeremy Thomas
    John M. S. Bartlett
    Breast Cancer Research and Treatment, 2012, 132 : 463 - 470
  • [35] Cytoplasmic and Nuclear HER4 Expression in HER2 Negative Breast Cancer Cell Lines
    Nafi, Siti Norasikin Mohd
    Ali, Nursyazana Aqilah
    SAINS MALAYSIANA, 2022, 51 (03): : 859 - 864
  • [36] EXPRESSION AND PROGNOSTIC VALUE OF HER3 AND HER4 IN MENINGIOMAS - AN IMMUNOHISTOCHEMICAL STUDY
    Arnli, M. B.
    Torp, S. H.
    NEURO-ONCOLOGY, 2018, 20 : 275 - 275
  • [37] Impact of HER2 codon 655 polymorphism and expression of HER2 and HER3 in non small cell lung cancer patients [Zur Bedeutung des HER2 Codon 655-Polymorphismus und der Expression von HER2 und HER3 bei Patienten mit einem nicht-kleinzelligen Lungenkarzinom]
    Ananiev J.
    Aleksandrova E.
    Skerleva D.
    Gulubova M.
    Chokoeva A.
    Lotti T.
    Wollina U.
    Tchernev G.
    Kontić M.
    Stojšić J.
    Wiener Medizinische Wochenschrift, 2015, 165 (15-16) : 315 - 321
  • [38] In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancer
    Spears, Melanie
    Taylor, Karen J.
    Munro, Alison F.
    Cunningham, Carrie A.
    Mallon, Elizabeth A.
    Twelves, Chris J.
    Cameron, David A.
    Thomas, Jeremy
    Bartlett, John M. S.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (02) : 463 - 470
  • [39] MEK inhibition leads to elevated HER3:PI3K in EGFR or HER2 driven cancer through feedback induction of HER1:3 and HER2:3 dimers
    Hoe, Nicholas
    Mateling, Michael
    Ma, Yating
    Jin, Kelly
    Zhou, JinYao
    Kirkland, Richard
    Kuy, Crystal
    Liu, Xinjun
    Kim, Phillip
    Singh, Sharat
    CANCER RESEARCH, 2013, 73 (08)
  • [40] The diverse signaling network of EGFR, HER2, HER3 and HER4 tyrosine kinase receptors and the consequences for therapeutic approaches
    Zaczek, A
    Brandt, B
    Bielawski, KP
    HISTOLOGY AND HISTOPATHOLOGY, 2005, 20 (03) : 1005 - 1015
12345